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Summary
PKC isoforms andCARMA1 play crucial roles in immu-
noreceptor-dependent NF-kB activation. We tested
whether PKC-dependent phosphorylation of CARMA1
directly regulates this signaling cascade. B cell anti-
gen receptor (BCR) engagement led to the progressive
recruitment of CARMA1 into lipid rafts and to the asso-
ciation of CARMA1 with, and phosphorylation by,
PKCb. Furthermore, PKCb interacted with the serine-
rich CARMA1 linker, and both PKCb and PKCq phos-
phorylated identical serine residues (S564, S649, and
S657) within this linker. Mutation of two of these sites
ablated the functional activity of CARMA1. In contrast,
deletion of the linker resulted in constitutive, receptor-
and PKC-independent NF-kB activation. Together, our
data support a model whereby CARMA1 phosphoryla-
tion controls NF-kB activation by triggering a shift
from an inactive to an active CARMA1 conformer.
This PKC-dependent switch regulates accessibility of
the CARD and CC domains and controls assembly
and full activation of the membrane-associated IkB
kinase (IKK) signalosome.
Introduction
Cell-surface receptor engagement initiates the cluster-
ing of signaling molecules into membrane-associated
complexesor ‘‘signalosomes’’ (Dustin and Colman, 2002;
Fruman et al., 2000). Scaffold proteins are critical for
these events by promoting the assembly of distinct sub-
sets of signaling molecules, coordinating receptor- and
lineage-specific control of downstream signals.
As an example in lymphocytes, engagement of the
BCR leads to the formation of a membrane lipid raft-
associated signaling complex (the ‘‘BCR signalosome’’)
composed of kinases, adaptors, and other effectors
(Guo et al., 2000), culminating in the activation of the
IkB kinase (IKK) complex that controls the NF-kB signal-
ing cascade. We have previously demonstrated that the
classical PKC isoform PKCb is a critical component of
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4 These individuals contributed equally to this work.this signalosome and is essential for recruitment and ac-
tivation of the IKK complex (Su et al., 2002). Thus, acti-
vated PKCb specifically orchestrates events essential
for BCR-dependent NF-kB signaling. The molecular
mechanisms by which PKCb activates the IKK complex
remain undetermined.
Similar to PKCb2/2 mice, mice lacking the CARD do-
main-containing protein Bcl10 lack BCR-dependent
NF-kB activation (Ruland et al., 2001). Bcl10-deficient
lymphocytes are also defective in PMA/ionomycin (P/I;
activators of PKC isoforms)-inducible NF-kB activation,
suggesting that PKCb and Bcl10 participate in a com-
mon NF-kB signaling pathway. Database searches and
screens for Bcl10-interacting proteins led to the identifi-
cation of a family of Bcl10-interacting proteins termed
CARMA1, 2, and 3 (Bertin et al., 2001; Gaide et al.,
2001; McAllister-Lucas et al., 2001). CARMA proteins
are comprised of five domains involved in protein-
protein interactions including an N-terminal CARD;
a coiled-coil (CC); a PDZ; and C-terminal SH3 and a
GUK-like domain. The C-terminal structure is analogous
to that of the MAGUK (membrane-associated guanylate
kinase homolog) family proteins that act as signaling
scaffolds in neuronal synapses (Dimitratos et al., 1999).
CARMA proteins also contain two large regions linking
these domains with unknown function. In this paper,
we refer to the 232 amino acids between the CC and
PDZ domains as the linker domain.
Overexpression of CARMA1 enhances PMA- and
Bcl10-dependent NF-kB activation that is blocked by
expression of CARMA1 lacking the Bcl10-interacting
CARD domain (Bertin et al., 2001; Gaide et al., 2002;
McAllister-Lucas et al., 2001), implying that CARMA1
acts upstream of Bcl10. CARMA1 expression is predom-
inantly restricted to lymphoid cells and is required for
T cell receptor (TCR)-induced NF-kB activation in cell
lines (Gaide et al., 2002; Pomerantz and Baltimore,
2002; Wang et al., 2002). Knockout studies demonstrate
an essential role for CARMA1 in immunoreceptor
(or P/I)-dependent NF-kB and JNK activation (Egawa
et al., 2003; Hara et al., 2003; Jun et al., 2003). CARMA1-
deficient mice display normal T, but impaired B-lineage
development. This phenotype closely resembles
PKCb2/2 mice (Leitges et al., 1996) with loss of BCR-
mediated B cell proliferation and ablation of B1 B cell de-
velopment and reduced immunoglobulin levels and anti-
body responses.
Together, these observations indicate that CARMA1
may organize an immunoreceptor-dependent ‘‘IKK
signalosome.’’ Here, we evaluate the role for PKCs
in CARMA1-mediated IKK activation. We demonstrate
that PKCb, CARMA1, Bcl10, and the IKK complex are co-
ordinately recruited into the BCR signalosome. This acti-
vation cascade is dependent upon CARMA1 interaction
with, and phosphorylation by, lipid-raft associated
PKCb, events that are essential for downstream NF-kB
activation. Finally, we show that functional interaction
of CARMA1 with PKCs represents a crucial conserved
mechanism essential for immunoreceptor-dependent
NF-kB signaling.
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CARMA1 Is Required for BCR-Induced
NF-kB Activation
We first verified a role for CARMA1 in BCR signaling and
the cellular models utilized in this study. The effect of
wild-type (wt) or mutant CARMA1 overexpression on
BCR-induced NF-kB activation was analyzed in the
chicken B cell line, DT40. As shown (see Figure S2A in
the Supplemental Data available with this article online),
expression of CARMA1 led to a dose-dependent in-
crease in NF-kB-induced reporter gene activity. In
contrast, expression of dominant-negative CARMA1
(DCARD-CARMA1) blocked BCR-dependent NF-kB
activity (Figure S1A). Stable overexpression of CARMA1
in Ramos B cells led to a w2-fold enhancement in IKK
phosphorylation and an increase in IkBa phosphor-
ylation and degradation in comparison to vector-
transduced cells (Figures S1B and S1C). The opposite
effect was again observed following introduction of
DCARD-CARMA1. In control experiments, wt or DCARD-
CARMA1 did not affect BCR-mediated ERK activation
or TNFa-triggered NF-kB activation (Figure S1B and
data not shown). These data indicate that CARMA1 func-
tions upstream of IKK in response to BCR stimulation.
To further evaluate the role for CARMA1 in BCR-depen-
dent NF-kB signaling, we used RNA interference to target
human CARMA1 in B cells. Human B cell lines stably ex-
pressing a short hairpin RNA targeting CARMA1 had a
60%–80% reduction in endogenous CARMA1 (data not
shown). BCR-dependent IkBa degradation was signifi-
cantly reduced in these cells (Figure S1D), to levels similar
to cells expressingDCARD-CARMA1. In contrast, ERK ac-
tivation and TNFa-dependent NF-kB activation were unal-
tered. Taken together, these results confirm that CARMA1
plays an essential role in BCR-induced NF-kB activation.
PKCb, CARMA1, Bcl10, and the IKK Complex Are
Coordinately Recruited into the BCR Signalosome
To determine whether CARMA1 is associated with the
BCR signalosome, membrane lipid rafts isolated from
BCR-stimulated Ramos or BJAB B cells were analyzed
for endogenous CARMA1, PKCb, Bcl10, and IKK pro-
teins by Western blot. A limited fraction of endogenous
CARMA1 was constitutively associated with lipid rafts
in unstimulated cells, and this fraction increased signif-
icantly following BCR engagement, peaking at 10–30
min (Figures 1A and 1B). Bcl10 was not present in rest-
ing cell rafts, but was progressively recruited for up to
60 min following B cell activation. As previously de-
scribed (Su et al., 2002), BCR engagement also pro-
moted association of PKCb and the IKK complex to lipid
rafts (Figures 1B–1D). Raft recruitment of Myc-tagged
CARMA1 was also observed in stably transduced Ra-
mos and BJAB B cell lines (Figures 1C and 1D and not
shown). These findings suggest that BCR engagement
leads to the assembly of an IKK signalosome comprised
of PKCb, CARMA1, Bcl10, the IKK proteins, and likely
additional proteins responsible for NF-kB activation.
PKCb Is Required for CARMA1-Dependent
Activation of NF-kB Activity
The involvement of PKCb and CARMA1 in NF-kB activa-
tion and the coordinate recruitment of these proteinsinto lipid rafts led us to ask whether PKCb acts as an
upstream kinase regulating CARMA1 function. To inves-
tigate the requirement for PKCb in the recruitment or
retention of CARMA1 to lipid rafts, B cells stably ex-
pressing Myc-tagged wtCARMA1 were treated with a
PKCb-specific inhibitor, Ly379196, followed by Western
blot. Inhibition of PKCb kinase activity significantly re-
duced the translocation of CARMA1, Bcl10, and the
IKK complex to lipid raft fractions (Figures 1C and 1D).
In contrast, Ly379196 had no effect on the level of Lyn
within raft fractions or on the recruitment of PKCb to
rafts, suggesting that initial raft integrity and early prox-
imal signals were unaltered by Ly379196.
CARMA1 Associates with PKCb in Human B Cells
We next performed immunoprecipitation (IP) studies
to test whether PKCb and CARMA1 physically interact
in vivo. Using isoform-specific antibodies, PKCb1 or
PKCb2 were IPed from untreated or anti-IgM-stimulated
cells. CARMA1 was detected in PKCb IPs from both
stimulated and nonstimulated B cells (Figure 2A). In re-
ciprocal studies, both isoforms of PKCb were also de-
tected in CARMA1 IPs (Figure 2B). No background co-
purification was observed using control murine and rabbit
antibodies. The amount of PKCb2 in anti-Myc IPs, and of
Myc-tagged CARMA1 in PKCb2 IPs, increased upon re-
ceptor engagement. These results suggest that PKCb is
constitutively associated with CARMA1 and that cell ac-
tivation enhances this interaction.
To identify protein domains of CARMA1 interacting
with PKCb, a GST pull-down assay was performed (Fig-
ure 2C). GST proteins containing the linker (GST2 and
GST4) interacted strongly with purified PKCb. Weak in-
teractions with PKCb were observed with GST-fusion
proteins containing either the PDZ-SH3 or GUK do-
mains. In contrast, proteins containing the N-terminal
domains of CARMA1, and GST alone, failed to interact
with PKCb. Further, we did not detect an interaction be-
tween PKCb and the downstream effector Bcl10. Thus,
PKCb interacts with the linker in vitro, and domains
within the MAGUK region may further facilitate this inter-
action.
CARMA1 Is a Direct Substrate of PKCb
In Vivo and In Vitro
Interaction of PKCb with CARMA1, and the ablation of
IKK activation by inhibition of PKCb expression or activ-
ity, suggest a role for PKCb in CARMA1 regulation. Such
regulation might be achieved by direct phosphorylation
of CARMA1. We examined whether CARMA1 associated
in vivo with a serine/threonine kinase. IPs of Myc-tagged
CARMA1 were utilized in an in vitro kinase (IVK) assay.
As shown in Figure 3A, phosphorylation of CARMA1 in-
creased significantly in activated B cells, and this phos-
phorylation was abrogated by treatment with Ly379196.
These results indicated that CARMA1 interacts with, and
is phosphorylated by, a PKCb-dependent kinase that is
activated in vivo upon BCR crosslinking.
We next tested whether BCR engagement leads to
PKC-dependent phosphorylation of CARMA1. Whole-
cell lysates (Figure 3B), or CARMA1 IPs from pooled
membrane raft fractions (Figure 3C), were probed with
an antibody that is specific for serine residues phos-
phorylated by conventional PKC isoforms (PKCa,b,g).
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(A) CARMA1 translocates to the lipid raft fraction after BCR engagement. The distribution of endogenous CARMA1 (top) and Bcl10 (middle) to
lipid rafts in Ramos and BJAB B cells 2 min after BCR engagement visualized by Western blot. The presence of constitutively raft-associated Lyn
(bottom) was determined as a loading and fractionation control.
(B) Progressive accumulation of PKCb2, CARMA1, Bcl10, and IKK in lipid rafts after IgM stimulation. Ramos B cells were stimulated with anti-IgM
as indicated, and raft and soluble fractions were serially analyzed for endogenous CARMA1, Bcl10, IKKa and b, PKCb2, and Lyn.
(C) Inhibition of PKCb blocks immunoreceptor-induced recruitment of CARMA1 to rafts. Ramos cells stably expressing Myc-tagged CARMA1
were pretreated with the PKCb-specific inhibitor Ly379196 and stimulated with IgM. After fractionation, lipid raft-associated proteins were blot-
ted for Myc-CARMA1, Bcl10, and IKKa/b and for Lyn as a loading control.
(D) Dosage effect of PKCb inhibition on CARMA1 lipid raft recruitment. Ramos B cells stably expressing Myc-CARMA1 were pretreated with the
indicated concentrations of Ly379196 for 10 min, stimulated with anti-IgM, and raft and soluble fractions were immunoblotted as in (C).CARMA1 exhibited inducible cPKC substrate immuno-
reactivity that was blocked by treatment with the PKCb-
specific inhibitor (Figure 3B). In contrast, CARMA1
phosphorylation in B cells was unaffected by treatment
with Rottlerin, an inhibitor of novel PKC isoforms (data
not shown). We also evaluated the phosphorylation
status of CARMA1 in primary B cells from wt versus
PKCb2/2mice. BCR-inducible cPKC substrate immuno-
reactivity was significantly reduced in PKCb2/2spleno-
cytes (Figure 3D). Together, these observations strongly
suggest that PKCb directly phosphorylates CARMA1 in
response to BCR engagement.
We also determined whether CARMA1 was a direct
substrate for PKCb in vitro. CARMA1 GST fusion pro-
teins (as in Figure 2C) were utilized in IVK assays along
with recombinant PKCb and [g-32P]ATP. Direct autoradi-
ography demonstrated phosphorylation specific to con-
structs containing linker (GST4; Figure 4A, left), indicat-
ing that the CARMA1 linker is the site of both PKCb
interaction and transphosphorylation.Parallel to PKCb in B cells, PKCq is required
(along with CARMA1) for TCR-dependent activation of
NF-kB in T cells (Coudronniere et al., 2000; Lin et al.,
2000; Sun et al., 2000). As it has recently been shown
that PKCq interacts with CARMA1 in vitro (Wang et al.,
2004), we hypothesized that PKCq may also regulate
CARMA1 activity via site-specific phosphorylation. By
utilizing PKCq for IVK assays described above, we
found that the linker of CARMA1 was also uniquely
and specifically phosphorylated by PKCq (Figure 4A,
middle).
Bcl10 exhibits a marked phosphorylation-dependent
molecular weight increase in response to PKC activa-
tion, BCR/TCR engagement, or CARMA overexpression
in T cells (Gaide et al., 2001; McAllister-Lucas et al.,
2001). As shown in Figure 4A, neither PKC isoform di-
rectly phosphorylated GST-Bcl10 in IVK assays, nor in-
teracted in our pull-down assays (Figure 2C). Together,
these findings indicate that PKC isoforms play a specific,
direct, and proximal role in activation of CARMA1.
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within the CARMA1 Linker
The linker is significantly enriched in serine and threo-
nine residues (49 of 231 amino acids; 21.2% S/T con-
tent), with a frequency in serine residues equivalent to
the top 1% of known murine sequences (http://www.
isrec.isb-sib.ch/software/SAPS_form.html). Sequence
Figure 2. PKCb Directly Associates with CARMA1 through Interac-
tion with the CARMA1 Linker
(A) CARMA1 co-IPs with PKCb in B cells. Whole-cell lysates from
control or IgM-stimulated Ramos cells stably expressing Myc-
CARMA1 were IPed with anti-PKCb1, anti-PKCb2, or anti-IgG iso-
type control, then immunoblotted to detect copurification of Myc-
CARMA1 (top).
(B) PKCb co-IPs with CARMA1 in a BCR stimulation-dependent
manner. In a reciprocal experiment, anti-Myc IPs of cell lysates
were Western blotted to detect copurifying endogenous PKCb1 or
PKCb2. As a control, blots (A) and (B) were stripped and reprobed
with the IP antibodies, shown below each panel.
(C) CARMA1 and PKCb form a stable interaction in vitro. Schematic
of CARMA1 domains used to generate GST-fusion proteins (top).
Purified GST fusion proteins were quantified, and equal amounts
were incubated with recombinant human PKCb1. Protein complexes
were pulled down with glutathione-sepharose and separated by
SDS-PAGE. Immunoblot using anti-PKCb1 antibody is shown (bot-
tom). This assay utilized equal amounts of the identical GST-fusion
preparations shown in Figure 4A (right).analysis of this region (http://scansite.mit.edu/) identi-
fied six putative PKC substrate sites (Figure 4B). To de-
termine PKC phosphorylation sites within this domain,
we first evaluated a large panel of GST-linker fusion pro-
teins containing clustered serine-to-alanine point muta-
tions (Figure 4B). This panel spanned each of the putative
PKC consensus sites as well as nearly all serine-rich
clusters within the linker (GST4 mutants, M1–12, contain-
ing mutations of 29/38 serine and 1/11 threonine resi-
dues). Each mutant fusion protein was utilized in IVK
assays along with recombinant PKCb or PKCq and
[g-32P]ATP. Only two mutations, M7 and M12, reduced
the amount of radiolabeled phosphate transferred to
GST4 (Figure S2B). We then narrowed the potential ser-
ine or threonine target sites by creating fusion proteins
with single or additive point mutations (Figures 4C and
4D). These experiments led to the identification of three
serine residues, S564, S649, and S657, which represent
the major sites for linker phosphorylation by PKCb or
PKCq. Mutation of all three residues led to a >90% and
70% reduction in PKCq- and PKCb-mediated linker
phosphorylation, respectively. The greater residual
radiolabel signal observed in PKCb assays suggests
the presence of an additional, not yet identified, in vitro
PKCb phosphorylation site. To verify that these sites
are phosphorylated in vivo, DT40 cells were transfected
with full-length Myc-wtCARMA1 or CARMA1 S564,649,
657A (Figure 4F), followed by anti-phospho-cPKC sub-
strate IP of unstimulated or P/I-stimulated cells. Myc
Western blot of the IPs showed that wtCARMA1 is indu-
cibly phosphorylated by P/I stimulation on immuno-
reactive serine residues. P/I-inducible phospho-cPKC
substrate immunoreactivity was abolished in cells trans-
fected with CARMA1 S564,649,657A, confirming that
these residues are targets of PKC phosphorylation
in vivo.
Loss of Linker Phosphorylation Abrogates
CARMA1-Mediated NF-kB Activation
We next determined whether mutation of linker phos-
phorylation sites would alter CARMA1 function. We uti-
lized a transient transfection assay in Jurkat T cells (Fig-
ure 4E), as this line provided a more sensitive system
in which to assay functional effects (due to the higher
inducible NF-kB reporter activity; w10-fold versus
w2-fold compared to DT40 B cells). Strikingly, mutation
of two of the phosphorylation sites identified in vitro led
to partial (S657A) or complete (S564A) abrogation of in-
ducible CARMA1 activity. CD3/CD28-dependent NF-kB
activation in cells expressing the S564A mutant was
identical to that in empty vector-transfected cells. Muta-
tion of S657 decreased NF-kB activation to <40% of that
of wtCARMA1. Mutation of both residues led to a com-
plete loss of inducible NF-kB activity (not shown). Muta-
tion of the third residue identified in vitro, S649A, had no
significant effect on NF-kB activation. Mutation of other
putative PKC sites not phosphorylated in vitro (S515A,
S620A) or residues not phosphorylated in vitro nor pre-
dicted to be recognition sites for serine/threonine
kinases (M6 and others [not shown]) also had no effect
in this assay. These data provide strong evidence that
PKC-mediated phosphorylation of S564 and S657 within
the CARMA1 linker is required for CARMA1 activation.
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565Figure 3. BCR Crosslinking Induces PKCb-Dependent Serine Phos-
phorylation of CARMA1
(A) A CARMA1-containing protein complex purified from B cells
phosphorylates CARMA1 after IgM stimulation and is sensitive to
the presence of a PKCb inhibitor. Ramos B cells expressing Myc-
CARMA1 were pretreated with or without Ly379196 and stimulated
with anti-IgM as indicated. Protein complexes purified from cell ly-
sates by anti-Myc IP were incubated in PKCb activation buffer in
the presence of [g-32P]ATP and visualized by autoradiography.
The location of phosphorylated CARMA1 is indicated (top). Frac-
tions of the IPs were probed with an anti-Myc antibody as a loading
control (bottom).
(B) CARMA1 exhibits inducible phosphorylation of classical-PKC-
consensus site serine residues in response to IgM stimulation that
is sensitive to PKCb inhibition. Whole-cell lysates obtained from
anti-IgM-stimulated Myc-CARMA1-expressing Ramos cells as de-
scribed in (A) were immunoblotted with anti-phospho(Ser)cPKC
substrate antibody (top). Blots were stripped and reprobed with
anti-Myc antibody to evaluate loading (bottom).
(C) Lipid raft recruited CARMA1 is serine phosphorylated after IgM
stimulation. Raft fractions were obtained from untreated or anti-
IgM-stimulated (10 min) Ramos B cells. Pooled raft fractions were
IPed with an anti-Myc antibody and blotted with an anti-phospho-
(Ser)cPKC substrate antibody (top). The blot was stripped and re-
probed with anti-Myc (bottom).
(D) CARMA1 PKC-consensus site phosphorylation is markedly re-
duced in PKCb-deficient mice. Splenocytes were isolated from wt
or PKCb2/2 mice and left untreated or stimulated for the times indi-
cated with anti-IgM. Whole-cell lysates were immunoblotted with
anti-phospho-(Ser)cPKC substrate antibody. Blots were stripped
and reprobed with anti-CARMA1 or anti-actin antibodies to evaluate
loading. The migration of CARMA1 in whole-cell lysates was alsoThe CARMA1 CARDDomain Interacts with the Linker
While the CARD domains of Bcl10 and CARMA1 interact
with high affinity (Bertin et al., 2001; Gaide et al., 2001),
colocalization of CARMA1 with Bcl10 requires antigen
receptor engagement (Figures 1B–1D; Egawa et al.,
2003; Gaide et al., 2002). Together with our data, this
suggests that linker phosphorylation triggers a change
in the accessibility of the CARMA1 CARD domain. To
test this model, we performed GST pull-down assays
to identify potential interactions among candidate do-
mains of CARMA1. GST fusion proteins (as in Figure
2C) were incubated with a 35S-methionine-labeled frag-
ment encoding the combined CARD-CC domains. This
fragment did not exhibit binding to the MAGUK region
or GST alone. In contrast, it consistently interacted
with the linker (Figure 5A). To further map this inter-
action, we used a radiolabeled CC-only fragment. In
contrast to CARD-CC, the CC-only fragment failed to in-
teract with the linker (data not shown). Both the CARD-
CC and CC-only fragments interacted with proteins en-
coding the CC domain (Figure 5A and data not shown),
consistent with its role in protein oligomerization (Bur-
khard et al., 2001). The CARD-CC fragment also inter-
acted with GST-Bcl10 (Figure 5A), as previously shown.
Although these latter interactions were reproducibly
demonstrated, we consistently observed a higher level
of CARD-CC signal within pull-downs performed using
the CARMA1 linker region. While we have been unable
to directly evaluate a CARD-only fragment (due to ineffi-
cient radiolabeling based upon its amino acid content),
our findings are consistent with a direct interaction be-
tween the CARMA1 CARD and linker domains.
We hypothesized that PKC phosphorylation of the
linker would alter its interaction with the CARMA1 CARD
domain. GST-linker constructs phosphorylated in vitro
by PKCq exhibited a 3-fold reduction in CARD:linker
binding (average change: 3.1-fold 6 0.1-fold SD; n = 3).
In contrast, the S564,657A mutation blocked this phos-
phorylation-dependent reduction in CARD:linker binding
(Figure 5B, right). Mutation of the most highly conserved
(but nonphosphorylated) serine residue within the linker
(S577; see below) did not alter the phosphorylation-
dependent reduction in CARD binding (data not shown).
Together, these data support the model that PKC phos-
phorylation alters a basal CARMA1 CARD:linker intramo-
lecular interaction.
Deletion of the Linker Leads to Constitutive
NF-kB Activation
An intramolecular CARD:linker interaction would likely
limit the assembly of an active CARMA1 signaling
complex. Disruption of this interaction via linker phos-
phorylation could trigger structural changes required
for recruitment of downstream effectors such as Bcl10.
We tested this idea by evaluating the activity of CARMA1
lacking the linker (Dlinker-CARMA1). We performed
NF-kB-luciferase reporter gene assays in DT40 or
Jurkat cells transfected with vector alone, wtCARMA1,
DCARD-CARMA1, or Dlinker-CARMA1 (Figure 5D).
identified using IPed CARMA1 (from Myc-CARMA1-expressing
Ramos cells) run on the same gel and immunoblotted with anti-
Myc and anti-CARMA1 antibodies (far right lane).
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567Overexpression of wtCARMA1 increased immunorecep-
tor-dependent NF-kB activation (by 2- and 4.2-fold over
vector control in B and T cell lines, respectively). In con-
trast,DCARD-CARMA1 expression inhibited NF-kB acti-
vation (reduction of 4.2- and 1.9-fold, respectively).
Dlinker-CARMA1 promoted a striking increase in consti-
tutive NF-kB activation in both B and T cell lines. In B
cells, Dlinker-CARMA1 expression led to basal NF-kB
activation comparable to that of BCR-stimulated cells
overexpressing wtCARMA1. In T cells, expression of
Dlinker-CARMA1 increased basal NF-kB activity >100-
fold in comparison to vector- or wtCARMA1-transfected
cells. Further, NF-kB activity inDlinker-CARMA1-express-
ing cells was 6-fold greater than the CD3-CD28-stimu-
lated activity in cells overexpressing the wtCARMA1.
Thus, deletion of the linker promotes constitutive NF-
kB activation in lymphoid cells, further demonstrating
the crucial role for this domain in CARMA1 regulation.
Distinct Linker Subdomains Function Coordinately
to Promote CARMA1 Activation
Computational analysis of the linker identified an amino-
terminal NORS (no regular secondary structure) subdo-
main, >80% of which is nonstructured, flexible loops
(Figure 5C; amino acids 441 through 519 of muCARMA1;
Liu and Rost, 2003). This subdomain is absent in
CARMA2 and 3. NORS regions are as evolutionarily con-
served as flanking protein interaction domains, indicat-
ing their vital function. Connecting loop-type NORS,
like the linker, are thought to modulate the orientation
and activity of associated domains. We predicted that
the absence of a NORS region in the linkers of other
CARMA proteins constrains folding required for intra-
molecular interactions. Indeed, B and T cells expressing
a CARMA2-linker-substituted CARMA1 exhibited con-
stitutive NF-kB activity, comparable toDlinker-CARMA1
(Figure 5D). Similarly, deletion of as few as 19 aminoacids (Dloop) within the NORS region of CARMA1 was
sufficient for constitutive NF-kB activation (Figure 5E).
Residues immediately downstream of the S564 PKC
phosphorylation site comprise the only highly con-
served pocket within the linkers of each of the human
and murine CARMA1-3 family proteins. This region (that
includes 7 invariant and 11 consensus residues among
22 total amino acids; 566–587) is predicted to form a
b strand followed by a short helical region (Figure 5C).
This region also contains the only serine residues,
S567 (a predicted PKC site) and S577 (not a predicted
PKC site), fully conserved among all CARMA family pro-
teins. Neither S567 nor S577 is phosphorylated in vitro
(Figure 4C). These serines are located next to a region
of predicted ambivalent protein structure (ASP analysis
at PredictProtein at http://cubic.bioc.columbia.edu) that
may facilitate a conformational change. Mutation of ei-
ther of these serine residues (to alanine) eliminates this
predicted ASP sequence, and mutation of either residue
abrogated the CARMA1 activation (Figure 5E). Notably,
a GST-linker construct containing the S577A mutation
consistently bound radiolabeled CARD-CC fragment
with higher affinity than the wt linker (Figure 5A). Deletion
of this putative CARD binding pocket (Dstand-helix3)
promoted constitutive NF-kB activation (Figure 5E), con-
sistent with a loss of an autoinhibitory binding interaction.
The S649 and S657 phosphorylation sites are located
next to one of four predicted helices in the linker. Dele-
tion of this helix (Dhelix4) also led to constitutive NF-
kB activation (Figure 5E). This suggests a potential role
for phosphorylation in modifying helix4 and its binding
interactions. In contrast to the effects of deletion of the
NORS or PKC-site proximal regions, deletion of the
other predicted helical regions within the linker (Dhelix1
orDhelix2) had no effect on CARMA1 activity (Figure 5E).
This indicates that truncation of the linker alone is not
sufficient to generate an activated phenotype. TheseFigure 4. Serine Residues within the CARMA1 Linker Are Phosphorylated by PKCb and PKCq and Are Required for Downstream Activation of NF-kB
(A) The linker is directly phosphorylated by PKCb and PKCq in vitro. GST fusion proteins were subjected to an IVK assay with either purified
human PKCb (left) or PKCq (middle), followed by SDS-PAGE and direct autoradiography. Asterisks indicate the position of bands corresponding
to autophosphorylated PKC, and arrows show the location of phosphorylated GST CARMA1 fusion proteins. Purified GST fusion proteins were
separated by SDS-PAGE and immunoblotted with an anti-GST antibody to assess protein loading (right).
(B) Amino acid sequence and secondary structure of the CARMA1 linker domain. Shown is the amino acid sequence of the murine linker (84.4%
identity to human). Multiple serine/threonine residues were mutated to alanine by site-directed mutagenesis. A total of 12 mutagenesis con-
structs (M1 through M12) were initially evaluated. Residues altered in each construct are indicated below the amino acid sequence. Serines
that scored as putative PKC substrates by computer analysis are indicated with green asterisks. Residues highlighted in yellow were directly
phosphorylated by PKCs in vitro (see [C] and [D]). Amino acids conserved within all human and murine CARMA1, 2, and 3 isoforms are high-
lighted with orange triangles. Consensus secondary structure (http://pbil.ibcp.fr/htm/index.php) predicts that 75% of the amino acids in the
linker form random coils or loops (black text), 9% form b strands (blue text), 14% a helices (red text), and 2% are of ambiguous structure.
(C and D) Serines 564, 649, and 657 within the linker are specifically phosphorylated by PKCq and PKCb. wtGST4 and GST4 constructs with single
or combined serine-to-alanine point mutations were incubated with PKCq (C) or PKCb (D) and [g-32P]ATP. Autoradiographs of SDS-PAGE gels
showing phosphorylated linker proteins (top). Relative phospho-GST4 signal of wt and mutant linker proteins determined as described in Exper-
imental Procedures (middle). Data shown are average values from three independent experiments. Western blot indicating loading of GST con-
structs (bottom).
(E) The phosphorylation sites S564 and S657 are essential for CARMA1 activity. Constructs expressing Myc-CARMA1 with the indicated S-to-A
point mutations were tested for their ability to transactivate an NF-kB firefly luciferase reporter in Jurkat T cells. The relative ratio of firefly to
Renilla luciferase activities were normalized to the value obtained with the unstimulated empty vector control in each experiment. White bars
represent unstimulated cells, and black bars cells were stimulated with CD3/CD28. Values shown are the mean of four experiments, and error
bars depict the SD. A two-tailed t test of independent sample means was performed between each CD3/CD28-stimulated sample and the CD3/
CD28-stimulated wtCARMA1-positive control. zp < 0.01; *p < 0.005; **p < 0.001; ns = not significant. The relative expression level of each con-
struct was assessed by anti-Myc Western blot of transfected 293T cells (bottom).
(F) CARMA1 S564,649,657A is not efficiently phosphorylated in vivo. DT-40 B cells transiently transfected with Myc-CARMA1 or Myc-CARMA1
S564,649,657A (106/condition) were serum starved and left unstimulated (DMSO only) or stimulated with P/I (200 ng/ml:1 mg/ml) for 10 min. IPs
were carried out using the anti-pSerPKC substrate antibody followed by anti-Myc Western blot (top). Whole-cell lysates showed equal starting
protein equivalents (bottom). Representative data from one of two experiments are shown.
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(A) Identification of intramolecular CARMA1 interactions. GST fusion proteins (Figure 2C) were incubated with an in vitro translated 35S-methi-
onine-labeled CARMA1 CARD-CC protein (amino acids 1–441). CARD-CC proteins copurifying after extensive high salt washes were visualized
by SDS-PAGE and direct autoradiography (top). The amount of radiolabeled copurifying proteins was quantified by phosphorimager and ex-
pressed relative to the amount of full-length GST protein present in each reaction (bottom).
(B) The CARD:linker interaction is abrogated by PKC phosphorylation. Wild-type or mutant (S564,657A) GST4 fusion proteins were incubated
with, or without, active PKCq and ATP (as in Figure 4A) before GST pull-down (top). Coomassie-stained gel showing loading of GST4 proteins
in each reaction (bottom). Phosphorylation of GST4 proteins was confirmed using a parallel reaction with [g-32P]ATP (data not shown).
(C) Diagram of structural features of the CARMA1 linker. The predicted linker structure is comprised predominantly of random coil or loops and
short structured regions including 7 b strands (black bars) and 4 helices (gray ovals). A NORS region is present within the first 79 amino acids. A 22
amino acid segment, predicted to include several b strands and a helix (Dstrand-helix3), is conserved within all six of the human and murine
CARMA proteins. This region is immediately adjacent to the S564 phosphorylation site (present only in CARMA1) and includes two highly con-
served residues, S567 and S577, not phosphorylated by PKCs in vitro (Figure 4D). The S657 and S649 phosphorylation sites are located adjacent
to predicted helix 4. Regions deleted in mutants used to characterize structural requirements are depicted above the diagram: Dloop (19 amino
acid deletion; 460–478), Dhelix1 (4 amino acid deletion; 506–509), Dhelix2 (14 amino acid deletion; 516–529), Dstrand-helix3 (16 amino acid de-
letion; 569–584), and Dhelix4 (17 amino acid deletion; 633–649).
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phorylation mediates local structural changes that trig-
ger CARMA1 activation.
Deletion of the CARMA1 Linker Initiates Assembly
and Activation of the IKK Signalosome
We also tested how loss of an inhibitory intramolecular
interaction might impact the assembly and activation
of proximal effectors required for NF-kB signaling. We
first determined whetherDlinker-CARMA1 was constitu-
tively recruited to membrane lipid rafts, the functional
compartment for IKK signalosome assembly. DT40
and Jurkat cells transiently transfected with Myc-tagged
CARMA1 or Dlinker-CARMA1 were analyzed by immu-
nofluorescence microscopy (IF). IF via an anti-Myc anti-
body revealed a diffuse cytosolic staining pattern in cells
expressing wtCARMA1 (Figure 6A), consistent with our
previous biochemical analyses of endogenous and
overexpressed CARMA1 in B cell lines (Figure 1). In con-
trast, Dlinker-CARMA1 localized to the plasma mem-
brane in both B and T cell lines (Figure 6A). Analysis of
B and T cell lines stably expressing wt versus Dlinker-
CARMA1 also demonstrated localization of the mutant
protein to the cell membrane (Figure S3A). The differen-
tial localization of wt versus Dlinker-CARMA1 was con-
firmed using biochemical analysis (Figures 7A and 7B).
Similar results were obtained in stably transduced cell
lines (Figure S3B). Thus, deletion of the linker facilitates
recruitment or retention of the mutant protein within
lipid rafts.
We also used IF to determine whether linker deletion
promotes association of CARMA1 with its downstream
binding partners. DT40 and Jurkat cells were transiently
transfected with Myc-wt or Dlinker-CARMA1, with or
without Flag-Bcl10. In unstimulated B and T cells ex-
pressing wtCARMA1, the CARD-domain-interacting
Bcl10 was uniformly distributed within the cytoplasm
and nucleus (Figure 6A). In contrast, Bcl10 localized to
the cell periphery and strongly colocalized with Dlinker-
CARMA1 in cells expressing the mutant protein. We ob-
served a similar colocalization of Dlinker-CARMA1 with
activated IKKa/b (Figure 6B). wtCARMA1-transfected
cells displayed a faint cytoplasmic signal (similar to
secondary antibody alone) when stained with a phos-
pho-specific anti-IKK antibody. In contrast, Dlinker-
CARMA1-transfected cells exhibited a strong phospho-
IKK signal that localized to the plasma membrane and
colocalized with CARMA1. Several additional biochemi-
cal studies confirmed the coenrichment of Dlinker-
CARMA1 with both Bcl10 and the IKK complex (Figure
7B; Figure S3B; and data not shown).Our data suggest that the role for PKCb and q in BCR/
TCR activation of NF-kB is to modify the conformation of
the CARMA1 scaffold to allow assembly of the IKK sig-
nalosome. To confirm that PKC activity is not required
in the presence of a structurally permissive CARMA1
molecule, we tested whether PKC-specific inhibitors
could modulate NF-kB signaling in cells expressing wt
versusDlinker-CARMA1. As anticipated from the pheno-
type of PKCq-deficient T cells (Lin et al., 2000; Sun et al.,
2000), treatment with the novel PKC inhibitor, Rottlerin,
abrogated inducible signaling in T cells transfected
with either vector alone or wtCARMA1. In contrast, the
high basal and inducible NF-kB activation in cells ex-
pressing Dlinker-CARMA1 was unaffected by PKC inhi-
bition (Figure 7E). Taken together, our data strongly sup-
port the conclusion that the predominant role for PKC
isoforms in antigen receptor-mediated NF-kB signaling
is to modulate (via site-specific phosphorylation) acces-
sibility of CARMA1 downstream effector binding sites.
Discussion
This study defines the direct biochemical events linking
PKC signaling to immunoreceptor-dependent NF-kB
activation. We demonstrate that: (1) CARMA1 is required
for BCR-induced NF-kB activation; (2) PKCb, CARMA1,
Bcl10, and the IKK complex are coordinately recruited
to lipid rafts in response to BCR engagement; (3) the
activity of PKCb is required for inducible CARMA1 re-
cruitment; (4) PKCb directly interacts with and phos-
phorylates the CARMA1 linker; and finally, (5) this phos-
phorylation cascade promotes a conformational change
in CARMA1 that initiates assembly of the CARMA1/
IKK signalosome. Our data also indicate that a con-
served PKCq-regulated mechanism similarly coordi-
nates TCR-dependent NF-kB activation.
We have previously shown that activation of IKK, and
recruitment of the IKK complex to lipid rafts, is eliminated
in PKCb2/2 B cells (Su et al., 2002). This led us to ask
whether PKCb directly activates an adaptor or down-
stream kinase required for these events. While the inter-
mediary molecules linking PKC to IKK activities have not
been fully characterized, at least three proteins,
CARMA1, Bcl10, and MALT1, are known to be crucial
for downstream IKK activation. Loss of any of these pro-
teins results in a failure to activate NF-kB in response to
antigen receptor or P/I stimulation (Egawa et al., 2003;
Hara et al., 2003; Jun et al., 2003; Ruefli-Brasse et al.,
2003; Ruland et al., 2001, 2003). Our results confirm
that CARMA1 is required for BCR-induced NF-kB activa-
tion, supporting a hierarchical BCR-PKCb-CARMA1-(D) Deletion of the CARMA1 linker strongly promotes constitutive NF-kB activation. Transient activation of NF-kB firefly luciferase reporter gene
in DT40 B cells (left) and Jurkat T cells (right) cotransfected with the empty expression vector, wtCARMA1, dominant-negative CARMA1
(DCARD), Dlinker-CARMA1, or CARMA2 linker(C2 linker)-substituted-CARMA1. After transfection, cells were either unstimulated (white bars)
or stimulated (black bars) with IgM (DT40) or CD3/CD28 (Jurkat). The ratio of firefly to Renilla luciferase was normalized to the unstimulated vector
control in each sample. Shown is the mean of four experiments, with error bars indicating the SD. Results that differed significantly from
wtCARMA1 are indicated as in Figure 4E. nd = not determined.
(E) Mutation of structural elements within the linker profoundly affects CARMA1 function. Top: Myc-CARMA1 expression constructs having ei-
ther single serine-to-alanine point mutations (S567A or S577A) or short deletions (Dloop, Dhelix1, Dhelix2, Dstrand-helix3, Dhelix4) were tested
for their ability to direct TCR-inducible NF-kB activity (as in [D]). Note the expanded y axis scale for the right panel. White bars indicate unstimu-
lated cells, and black bars cells that were stimulated with CD3/CD28. Values shown are the mean of two to six experiments, and error bars depict
the SD. Bottom: Relative expression level of each CARMA1 construct was assessed by anti-Myc Western blot of transfected 293T cells. Western
blot for actin is shown as a loading control.
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(A) Bcl10 constitutively colocalizes with Dlinker-CARMA1. DT40 B cells and Jurkat T cells were transiently cotransfected with plasmids express-
ing Bcl10 and either CARMA1 (rows 1 and 3) or Dlinker-CARMA1 (rows 2 and 4) and were fixed and stained to visualize localization of the
CARMA1 (red; column 1) and Bcl10 (green, column 2). CARMA1 and Bcl10 fluorescent signals are shown merged (column 3) to allow visualization
of colocalized proteins (yellow). In each panel, a single plane deconvolved image shows the center of a transfected cell. DIC images are displayed
in column 4.
(B) Colocalization of phosphorylated IKK with Dlinker-CARMA1. Transiently transfected cells as described in (A) were fixed and stained to com-
pare localization of the Myc-tagged, wt, or Dlinker-CARMA1 (red; column 1) and endogenous phosphorylated IKK (green; column 2). Merged
images (column 3) were used to evaluate colocalization of proteins (yellow). A predominantly cytoplasmic signal from both endogenous
Bcl10 and pIKK are evident in the untransfected cells (columns 2 and 3) in (A) and (B), respectively. Representative images (evaluating a minimum
of 100 photographed cells/condition) from one of 2–3 independent experiments are shown.
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571Bcl10-IKK signaling pathway dependent upon the kinase
activity of PKCb. Treatment with a PKCb-specific inhibi-
tor, which blocks BCR-dependent NF-kB activation,
blocked recruitment of CARMA1, Bcl10, and IKK to
rafts. Recruitment of these effectors is also ablated in
PKCb2/2 primary B cells (Su et al., 2002; B.G. and
D.J.R., data not shown).
We directly demonstrate that covalent modification of
CARMA1 by PKCb is crucial for this signaling cascade.
We show that CARMA1 is phosphorylated on classical
PKC consensus site serine residues in response to
BCR engagement in vivo. This modification is specifi-
cally blocked by inhibition of PKCb activity and in
PKCb2/2 primary B cells. In vitro, we mapped PKCb
and PKCq CARMA1 phosphorylation to three serine res-
idues (S564, S649, and S657) within the linker. Mutation
of these residues abrogated the P/I-induced in vivo
phosphorylation of CARMA1 in B cells. Most impor-
tantly, mutation of two of these residues, S564 and
S657, was sufficient to ablate CARMA1-mediated NF-
kB transcriptional activation in T cells. Phosphorylation
of these key residues is facilitated via direct interaction
of PKCb (or of PKCq, as shown previously) (Wang
et al., 2004) with the CARMA1 linker. Our combined
data strongly support the conclusion that PKCb and
PKCq function analogously (via phosphorylation of key
residues within the CARMA1 linker) to coordinate BCR
and TCR/CD28-mediated NF-kB activation, respec-
tively. While our data demonstrate a crucial role for
two serines in these events, it remains possible that ad-
ditional residues might be targeted in vivo. Future anal-
yses using phosphospecific antibody reagents should
clarify these events.
Our data strongly suggest that PKC-triggered confor-
mational changes within CARMA1 directly regulate its
activity as a raft-associated scaffold mediating assem-
bly of the IKK signalosome. In resting human B cell lines
and primary murine B cells (B.G. and D.J.R., data not
shown), only a small proportion of CARMA1 is associ-
ated with lipid rafts. This fraction increased significantly
within minutes of BCR stimulation, as demonstrated
for endogenous and epitope-tagged wt and Dlinker-
CARMA1. This increase required PKC activation and
correlated with Bcl10, IKKg, and activated IKKa/b re-
cruitment. Consistent with a regulatory role for the linker
in this process, B and T cells expressing Dlinker-
CARMA1 drastically increased constitutive CARMA1
membrane recruitment, assembly of activated IKK, and
NF-kB activation. Deletion of the linker also eliminated
the requirement for PKC in this activation cascade.
Notably, we demonstrate an intramolecular interac-
tion between the N terminus of CARMA1 and its linker.
This interaction exhibited an affinity similar to, or greater
than, the well-described interaction between the CARD
domains of CARMA1 and Bcl10. We predict that PKC
binding and phosphorylation of the linker disrupts the
CARD:linker interaction, thereby altering the structural
conformation of CARMA1. Consistent with this, we
show that linker phosphorylation markedly reduces its
capacity to interact with the CARD domain; and further,
that mutation of the S564 and S657 phosphorylation
sites abrogates this inducible change in binding affinity.
The CARD:linker interaction is enabled by three struc-
tural features of the CARMA1 linker: a NORS subdomainand a putative ‘‘pocket’’ (strand-helix3) and a ‘‘helical
region’’ (helix4), each located next to a major PKC phos-
phorylation site. Deletion of the NORS region, or its sub-
stitution with a linker lacking a NORS, creates a consti-
tutively active CARMA1. Further, mutation of two
highly conserved residues within the linker pocket abro-
gated CARMA1 activity, while deletion of either the
pocket or the helical region enhanced NF-kB signaling.
In contrast, similar sized deletions of predicted struc-
tural motifs not located within immediate proximity to
the PKC sites had no effect on CARMA1 function. While
additional structural and binding affinity studies are re-
quired to fully define the CARD:linker and PKC:linker in-
teractions, our data support the hypothesis that the
pocket and helical regions comprise important CARD in-
teraction motifs within the linker, with the NORS sequen-
ces providing the structural flexibility essential to permit
an intramolecular interaction.
Our combined data support the following model for
regulation of CARMA1-mediated signaling (Figures 7C
and 7D): a limited fraction of CARMA1 basally localizes
to lipid rafts (requiring the SH3 domain) (Wang et al.,
2004). Receptor engagement promotes raft recruitment
of activated PKCb (or PKCq in T cells) and facilitates
PKC binding to the CARMA1 linker. PKCb phosphoryla-
tion of S564 and S657 leads to an alteration in regional
charge that reduces the affinity of an autoinhibitory in-
tramolecular CARD:linker interaction. This drives a con-
formational change resulting in: (1) the coassociation of
the CARMA1 CARD domain with a Bcl10/MALT1/Traf/
Ubiquitin complex (Bertin et al., 2001; Gaide et al.,
2001; Sun et al., 2004); (2) association of IKKg (and the
associated IKK complex) with the SH3 and/or PDZ
domains of CARMA1 (Stilo et al., 2004); and (3) CC
domain-mediated CARMA1 oligomerization. These com-
bined events function coordinately to generate a stable,
raft-associated platform that promotes assembly and
activation of the IKK signalosome (Sun et al., 2004;
Zhou et al., 2004). This model is consistent with a recent
study demonstrating the requirement for CARMA1 in
recruitment of IKK into the central immunological syn-
apse in activated T cells (Hara et al., 2004).
Notably, deletion of the linker eliminates the require-
ment for PKC in IKK signaling. This and the loss of func-
tion observed following mutation of the linker phosphor-
ylation sites strongly support the conclusion that the
CARMA1 linker represents the predominant target sub-
strate for PKC isoforms in immunoreceptor-dependent
NF-kB signaling. These findings also provide a context
for interpretation of several previous observations. First,
it has been suggested that PKC isoforms function via di-
rect phosphorylation of Bcl10 (Jun et al., 2003) or IKKb
(Lin et al., 2000). In contrast, Bcl10 is not a PKC sub-
strate in vitro, and NF-kB activation proceeds normally
in Rottlerin-treated T cells overexpressing Dlinker-
CARMA1. Second, Bcl10-mediated IKK activation has
been reconstituted in vitro in the absence of either
CARMA1 or PKC by the use of purified Bcl10, MALT1,
Traf6, ubiquitin ligase, Tak1, and IKK (Sun et al., 2004).
In contrast, assembly of an active holocomplex via
a Bcl10 affinity column and T cell lysates required the
use of P/I-stimulated cells. Our findings suggest that
this latter data reflects the requirement for PKC-acti-
vated CARMA1 to colocalize the oligomerized Bcl10/
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572Figure 7. Deletion of the Linker Promotes CARMA1 Association with Proximal NF-kB Effectors within Membrane Rafts and Eliminates the
Requirement for PKC
(A)Dlinker-CARMA1 is constitutively localized to raft-enriched B cell membrane fractions. DT40 B cells transiently transfected with wt orDlinker-
CARMA1 expression plasmids were fractionated to obtain cytosolic (first column), detergent-soluble membrane (DSM; second column), and de-
tergent-insoluble membrane (DIM; third column) fractions. Localization of CARMA1 proteins was determined by Western blot with anti-Myc (top).
Blots were reprobed to detect actin (bottom). See Figure S3B for a related data set.
(B) Dlinker-CARMA1 and the IKK complex are constitutively localized to raft-enriched membrane fractions in Jurkat T cells. Biochemical frac-
tionation was used to evaluate transfected Jurkat T cells as in (A). Western blots were serially probed to detect Myc-tagged CARMA1, IKKg
CARMA1 Phosphorylation Controls NF-kB Activation
573MALT1/Traf/Ubiquitin complex with IKKg. Similarly,
while targeting of NEMO to T cell rafts leads to a basal
increase in NF-kB signaling (Sebald et al., 2005; Weil
et al., 2003), this signal remains PKC inducible and is
blocked by PKC inhibition. We suggest that PKC-acti-
vated CARMA1 functions in this latter system to effi-
ciently colocalize its downstream effectors.
Based upon its pivotal role, we propose the designa-
tion of the CARMA1 linker as the ‘‘PKC-regulated do-
main’’ (PRD). This domain, physically and functionally,
links the combination of amino- (CARD and CC) and car-
boxy-terminal (MAGUK homology) domains that are
unique to CARMA family proteins. While our findings
highlight the regulation of CARMA1 by PKC isoforms,
it is likely that CARMA1 also modulates substrate acces-
sibility, or local activity, of additional downstream PKC
targets. Key targets may include components of the
JNK activation pathway, disrupted in both PKCb- (B.G.
and D.J.R., data not shown) and CARMA1-deficient lym-
phocytes (Egawa et al., 2003; Hara et al., 2003; Jun et al.,
2003).
Experimental Procedures
Antibodies and Expression Constructs
Anti-human CARMA1 (AL220) was a gift from Margot Thome.
Expression vectors for N-terminal Myc-tagged murine CARMA1
(pmCARMA1), DCARD, and the NF-kB reporter plasmid Igk2-IFN-
Luc have been described (Pomerantz et al., 2002). pRL-TK was ob-
tained from Promega (Madison, WI). Cloning details for other con-
structs and commercial antibodies are described in Supplemental
Data.
Cell Culture, Activation, Western Blot, and IP
Human B (Ramos and BJAB) and T (Jurkat) cell culture, murine sple-
nocyte isolation and activation, BCR stimulation, and Western anal-
yses were performed as described (Su et al., 2002). The chicken B
cell line DT40 was cultured as above with the addition of 1% chicken
serum. Ramos B cells stably expressing Myc-CARMA1 or Myc-
DCARD-CARMA1 were created as described for Jurkat cells (Pom-
erantz et al., 2002). Transient transfection of DT40 and Jurkat cells
for IP, fractionation, and immunofluorescence assays was carried
out using the Cell Line Nucleofector Kit T and protocols B-23 and
H-10, respectively (Amaxa Inc., Gaithersburg, MD). Western blots
were imaged by ECL and autoradiography, or by an Odyssey Infra-
red Imaging System (LI-COR Biotechnology, Lincoln, NE). Coomas-
sie-stained gels were quantified using the Odyssey Imaging System
or a Typhoon Variable Mode Imager (Amersham Biosciences). IPs
were performed using standard techniques and are described in de-
tail in Supplemental Data.
Cell Fractionation and IF
Lipid rafts were prepared by sucrose gradient centrifugation as de-
scribed (Guo et al., 2000; Su et al., 2002). Fractions were immuno-
blotted for Lyn and GM1 to confirm the presence of lipid rafts. Bio-
chemical separation of detergent-insoluble and detergent-soluble
membrane fractions (DIM and DSM, respectively) and cytosolic frac-
tions was performed as described (Khoshnan et al., 2000). Descrip-tions of IF procedures and suppliers can be found in Supplemental
Data.
Reporter Gene Assays
Transient transfection was achieved by electroporation (DT40 cells)
or by Superfect (Jurkat cells; Qiagen, Valencia, CA) as described in
detail in the Supplemental Data. For all reporter gene assays, cells
were harvested and luciferase activities measured using a Dual-
Luciferase assay kit (Promega). Firefly luciferase expression levels
were normalized to the Renilla luciferase transfection control. All
analyses included a minimum of three independent experiments.
Statistical significance was determined using a two-tailed t test of
independent sample means.
GST Pull-Down Assays and PKCb and PKCq IVK Assays
GST-fusion proteins expressed in BL21 E. coli were batch-purified
with Glutathione Sepharose 4B (Amersham Biosciences) according
to the manufacturer’s instructions. For pull-down assays, fusion
proteins conjugated to glutathione-sepharose beads were incu-
bated in binding buffer (60 mM NaCl, 1 mM EDTA, 20 mM Tris-HCl
[pH 8.0], 0.05% IGEPAL, 1 mM DTT, 6 mM MgCl2, 8% glycerol)
and either 2 ml of 35S-methionine-labeled in vitro translated protein
(TnT T7 Quick Coupled Transcription/Translation System, Promega)
or 50 ng of recombinant PKCb1. Mixtures were incubated at 4ºC
overnight and washed three times with >10 volumes of wash buffer
(binding buffer with 500 mM NaCl), and proteins were eluted and
separated by SDS-PAGE. Nonradiolabeled proteins were detected
by Western blot. Radiolabeled proteins were quantified using a
Typhoon Imager.
IVK assays of CARMA1 fragments were carried out using affinity-
purified GST fusion proteins and 25 ng of either purified recombinant
human PKCb1 or PKCb2 (Calbiochem, La Jolla, CA) or PKCq (Invi-
trogen, Carlsbad, CA). IVK of CARMA1 IPed from B cells was evalu-
ated without the addition of exogenous PKCs. Details of the IVK re-
action are provided in the Supplemental Data.
Supplemental Data
Supplemental Data include three figures and Supplemental Experi-
mental Procedures and can be found with this article online at
http://www.immunity.com/cgi/content/full/23/6/561/DC1/.
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(C and D) Working model for PKC-dependent CARMA1 activation.
(C) PKCb (or PKCq) induces a phosphorylation-dependent conformational shift in CARMA1 from an inactive ‘‘closed’’ (left) to an active ‘‘open’’
(right) conformation. See detailed discussion in the text.
(D) Deletion of the linker results in constitutive assembly of the CARMA1 signalosome in the absence of linker phosphorylation.
(E) Expression of Dlinker-CARMA1 eliminates the requirement for PKC in TCR-dependent NF-kB signaling. Jurkat T cells were transiently co-
transfected with a NF-kB luciferase reporter and tk-Renilla luciferase plasmids and either an empty, CARMA1, or Dlinker-CARMA1 expression
vector. 42 hr posttransfection, cells were pretreated for 15 min with either 0, 1, or 5 mM Rottlerin; and left unstimulated (white bars) or stimulated
with anti-CD3 and anti-CD28 antibodies (black bars) for 6 hr. Results of reporter gene activity assays are shown with error bars indicating the SD
from the mean of two independent experiments. Similar data were generated using transfected B cells expressing Dlinker-CARMA1 and treated
with the PKCb-specific inhibitor, Ly379196.
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